SSG Advises Eiger BioPharmaceuticals in the Sale of Lonafarnib and Lambda
SSG Capital Advisors served as the investment banker to Eiger BioPharmaceuticals in the sale of Lonafarnib and Lambda, and associated clinical assets, to Eiger InnoTherapeutics. The sale was effectuated through a chapter 11 section 363 process.
Read moreDetails









